(A) Kaplan-Meier overall survival curve of newly diagnosed multiple myeloma patients according to del(1p32) status. See Figure 2A in the article by Schavgoulidze et al that begins on page 1308. (B) Kaplan-Meier overall survival curve of newly diagnosed multiple myeloma patients with del(1p32) according to the association with other high-risk cytogenetic abnormalities, defined by the presence of del(17p), t(4;14), and/or gain(1q). See Figure 4 in the article by Schavgoulidze et al that begins on page 1308. (C) Kaplan-Meier overall survival curve by TP53 biallelic, monoallelic, or wild-type status. Reproduced from Walker et al,3 published under a CC BY 4.0 license (http://creativecommons.org/licenses/by/4.0/).
